Unique ID issued by UMIN | UMIN000012772 |
---|---|
Receipt number | R000014920 |
Scientific Title | Early specialty palliative care for patients with advanced lung cancer undergoing chemotherapy: Feasbility study |
Date of disclosure of the study information | 2014/01/07 |
Last modified on | 2024/01/10 16:21:15 |
Early specialty palliative care for patients with advanced lung cancer undergoing chemotherapy: Feasbility study
Early specialty palliative care for patients with advanced lung cancer undergoing chemotherapy: Feasbility study
Early specialty palliative care for patients with advanced lung cancer undergoing chemotherapy: Feasbility study
Early specialty palliative care for patients with advanced lung cancer undergoing chemotherapy: Feasbility study
Japan |
Advanced Lung Cancer
Hematology and clinical oncology |
Malignancy
NO
To examine the feasibility of specialty palliative care comprehensive program for hospitalized patients with advanced lung cancer undergoing first-line chemotherapy.
Others
Feasibility
Exploratory
Phase I,II
Completion rate of the questionnaires after second course of first-line chemotherapy
(1) Functional Assessment of Cancer Therapy-Lung(FACT-L)
(2) Patient Health Questionnaire 9(PHQ-9)
(3) Hospital Anxiety and Depression Scale(HADS)
(4) Rate of the patients received intervention of specialty palliative care service
(5) Contents of intervention performed by specialty palliative care service
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Behavior,custom | Other |
Patients with advanced lung cancer undergoing first-line platinum-based chemotherapy in hospital receive specialty palliative care comprehensive program. The program contains the promotion of the intervention with the brief questionnaire and the specialized palliative care comprehensive program with the nurse-centered interdisciplinary approach.
20 | years-old | <= |
Not applicable |
Male and Female
(1) histologically or cytologically proven stage IV non-small cell lung cancer or extended-disease small cell lung cancer.
(2) undergoing first-line platinum-based chemotherapy in hospital at National Cancer Hospital East.
(3) informed about the cancer by the physician.
(4) age >= 20 years.
(5) expected to survive for more than 3 months.
(1) recurrence after surgery for lung cancer.
(2) with severe cognitive impairment.
(3) already consulted outpatient palliative medicine clinic or outpatient psyco-oncology clinic before entry to this study.
(4) already received intervention of specialty palliative care service before diagnosis.
(5) participate in other intervention studies which prohibit participation in this study.
(6) unable to read and respond to questions in Japanese.
(7) judged to be inappropriate for participation to this study by the attending physician.
47
1st name | |
Middle name | |
Last name | Yoshihisa Matsumoto |
National Cancer Center Hospital East
Department of Palliative Medicine
6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577
+81-4-7133-1111
yosmatsu@east.ncc.go.jp
1st name | |
Middle name | |
Last name | Yoshihisa Matsumoto |
National Cancer Center Hospital East
Department of Palliative Medicine
6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577
+81-4-7133-1111
yosmatsu@east.ncc.go.jp
National Cancer Center Hospital East
Ministry of Health, Labour and Welfare
Japanese Governmental office
NO
2014 | Year | 01 | Month | 07 | Day |
Published
https://academic.oup.com/jjco/article/52/4/375/6515542?login=true
50
Completed
2012 | Year | 05 | Month | 26 | Day |
2012 | Year | 08 | Month | 06 | Day |
2014 | Year | 01 | Month | 07 | Day |
2024 | Year | 01 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014920
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |